QuidelOrtho Corp
QDEL- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001906324
No open-market purchases or sales by QuidelOrtho Corp insiders were filed in the last 90 days; 245 institutions reported holding it in 13F filings for Q2 2026, worth $1.45B in total; no superinvestor holds it.
Superinvestors holding QDEL, Q2 2026
No superinvestor reported holding QDEL in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of QDEL each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2026
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q4 2025
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−12.5%)
Q3 2025
1 superinvestor holding at quarter end
Q4 2024
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q3 2024
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−6.6%)
Q2 2024
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+27.5%)
Q1 2024
1 superinvestor holding at quarter end
Q3 2023
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q2 2023
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−20.1%)
Q1 2023
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+34.9%)
Q4 2022
1 superinvestor holding at quarter end
Q1 2022
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q4 2021
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−34.7%)
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−89.1%)
Q2 2021
1 superinvestor holding at quarter end